QureBio Secures Almost CNY 100 Million for Clinical Advancements in Biopharmaceuticals#China#Shanghai#antibody_therapeutics#Qure_Biotechnology#Efung_Capital
QureBio Secures Almost CNY 100 Million for Clinical Advancements in Biopharmaceuticals
Qure Biotechnology has successfully completed its Series C1 financing, raising nearly CNY 100 million, aiming to enhance clinical trials and develop innovative antibody therapeutics.
third-news.com
June 5, 2025 at 1:40 PM
QureBio Secures Almost CNY 100 Million for Clinical Advancements in Biopharmaceuticals#China#Shanghai#antibody_therapeutics#Qure_Biotechnology#Efung_Capital